Advertisement
Advertisement
TRLV
Trulieve Cannabis Corp.
11.32
USDSponsored
+0.18
+1.62%
Aug 25, 15:59 UTC -4
Closed
Pre-Market
11.32
0.00
0.00%
TRLV Earnings Reports
Positive Surprise Ratio
TRLV beat 1 of 3 last estimates.
33%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$223.91M
/$0.05
Implied change from Q2 26 (Revenue/ EPS)
-17.38%
/-102.38%
Implied change from Q3 25 (Revenue/ EPS)
--
/-135.71%
Trulieve Cannabis Corp. earnings per share and revenue
On Aug 07, 2026, TRLV reported earnings of -2.10 USD per share (EPS) for Q2 26, missing the estimate of 0.06 USD, resulting in a -3386.38% surprise. Revenue reached 271.00 million, compared to an expected 273.86 million, with a -1.05% difference. The market reacted with a -2.78% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 0.05 USD, with revenue projected to reach 223.91 million USD, implying an decrease of -102.38% EPS, and decrease of -17.38% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.27
Actual
$0.02
Surprise
+107.31%
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.16
Actual
$0.20
Surprise
+24.07%
Valneva SE - ADR
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.34
Surprise
-243.33%
Brainsway Ltd. - ADR
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.15
Actual
$0.14
Surprise
-7.65%
Capricor Therapeutics Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.70
Surprise
-16.32%
FitLife Brands, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.19
Actual
$0.20
Surprise
+0.55%
Immucell Corp
Report Date
Aug 13, 2026 For Q2 26
Estimate
-Actual
$0.20
Surprise
-
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.34
Surprise
-41.84%
FAQ
What were Trulieve Cannabis Corp.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Trulieve Cannabis Corp. reported EPS of -$2.10, missing estimates by -3386.38%, and revenue of $271.00M, -1.05% below expectations.
How did the market react to Trulieve Cannabis Corp.'s Q2 2026 earnings?
The stock price moved down -2.78%, changed from $9.00 before the earnings release to $8.75 the day after.
When is Trulieve Cannabis Corp. expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Trulieve Cannabis Corp.'s next earnings report?
Based on --
analysts, Trulieve Cannabis Corp. is expected to report EPS of $0.05 and revenue of $223.91M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement